Alkermes plc (ALKS) Downgraded to Underperform by B of A Securities

Market Context

Alkermes plc operates in the Healthcare sector. The stock currently trades at $52.53 with a market capitalization of $5.0B. The stock has gained 82.1% over the past 52 weeks.

Analyst downgrades can weigh on a stock in the short term as institutional investors who follow B of A Securities's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Alkermes plc

Among the 10 most recent ratings: 9 Buy, 0 Hold, 1 Sell.

Date	Firm	Rating	Price Target
Jun 29, 2026	Wells Fargo	Overweight	N/A
Jun 29, 2026	B of A Securities	Underperform	N/A
Jun 24, 2026	Needham	Buy	N/A
Jun 22, 2026	TD Cowen	Buy	N/A
Jun 18, 2026	Needham	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View ALKS Stock Page